Basit öğe kaydını göster

Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia - A retrospective analysis of a double-blind trial and an open-label extension

dc.contributor.authorTekin, Sibel
dc.contributor.authorEmre, Murat
dc.contributor.authorDe Deyn, Peter Paul
dc.contributor.authorKirsch, Courtney
dc.contributor.authorHsu, Chuanchieh
dc.contributor.authorLane, Roger
dc.contributor.authorOertel, Wolfgang
dc.contributor.authorPoewe, Werner
dc.contributor.authorWolters, Erik
dc.date.accessioned2021-03-03T15:54:22Z
dc.date.available2021-03-03T15:54:22Z
dc.date.issued2008
dc.identifier.citationOertel W., Poewe W., Wolters E., De Deyn P. P. , Emre M., Kirsch C., Hsu C., Tekin S., Lane R., "Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia - A retrospective analysis of a double-blind trial and an open-label extension", DRUG SAFETY, cilt.31, sa.1, ss.79-94, 2008
dc.identifier.issn0114-5916
dc.identifier.othervv_1032021
dc.identifier.otherav_41685bfe-d527-4747-9973-1fa721ca870d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/47703
dc.identifier.urihttps://doi.org/10.2165/00002018-200831010-00007
dc.description.abstractBackground and aim: Rivastigmine is now widely approved for the treatment of mild to moderately severe dementia in Parkinson's disease (PDD). However, since anticholinergic drugs have a role in the management of tremor in patients with Parkinson's disease (PD), concerns have been raised that the use of cholinergic drugs might worsen PD. The current analyses were performed to examine the potential of rivastigmine to affect tremor and other motor symptoms in patients with PDD.
dc.language.isoeng
dc.subjectMeslek Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectSosyal ve Beşeri Bilimler
dc.subjectSosyal Bilimler (SOC)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTOKSİKOLOJİ
dc.subjectSağlık Bilimleri
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectSosyoloji
dc.subjectFarmasötik Toksikoloji
dc.subjectKAMU, ÇEVRE VE İŞ SAĞLIĞI
dc.subjectSosyal Bilimler Genel
dc.titleEffects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia - A retrospective analysis of a double-blind trial and an open-label extension
dc.typeMakale
dc.relation.journalDRUG SAFETY
dc.contributor.departmentPhilipps University Marburg , ,
dc.identifier.volume31
dc.identifier.issue1
dc.identifier.startpage79
dc.identifier.endpage94
dc.contributor.firstauthorID186345


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster